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Cyclization of the intrinsically disordered a1Sdihydropyridine receptor II-III loop
enhances secondary structure and in vitro function
Abstract
A key component of excitation contraction (EC) coupling in skeletal muscle is the cytoplasmic linker (II-III
loop) between the second and third transmembrane repeats of the α1S subunit of the dihydropyridine
receptor (DHPR). The II-III loop has been previously examined in vitro using a linear II-III loop with
unrestrained N- and C-terminal ends. To better reproduce the loop structure in its native environment
(tethered to the DHPR transmembrane domains), we have joined the N and C termini using inteinmediated technology. Circular dichroism and NMR spectroscopy revealed a structural shift in the cyclized
loop toward a protein with increased α-helical and β-strand structure in a region of the loop implicated in
its in vitro function and also in a critical region for EC coupling. The affinity of binding of the II-III loop
binding to the SPRY2 domain of the skeletal ryanodine receptor (RyR1) increased 4-fold, and its ability to
activate RyR1 channels in lipid bilayers was enhanced 3-fold by cyclization. These functional changes
were predicted consequences of the structural enhancement. We suggest that tethering the N and C
termini stabilized secondary structural elements in the DHPR II-III loop and may reflect structural and
dynamic characteristics of the loop that are inherent in EC coupling.
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Cyclization of the Intrinsically Disordered ␣1S
Dihydropyridine Receptor II-III Loop Enhances Secondary
Structure and in Vitro Function*□
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A key component of excitation contraction (EC) coupling in
skeletal muscle is the cytoplasmic linker (II-III loop) between
the second and third transmembrane repeats of the ␣1S subunit
of the dihydropyridine receptor (DHPR). The II-III loop has
been previously examined in vitro using a linear II-III loop with
unrestrained N- and C-terminal ends. To better reproduce the
loop structure in its native environment (tethered to the DHPR
transmembrane domains), we have joined the N and C termini
using intein-mediated technology. Circular dichroism and
NMR spectroscopy revealed a structural shift in the cyclized
loop toward a protein with increased ␣-helical and ␤-strand
structure in a region of the loop implicated in its in vitro function and also in a critical region for EC coupling. The affinity of
binding of the II-III loop binding to the SPRY2 domain of the
skeletal ryanodine receptor (RyR1) increased 4-fold, and its ability to activate RyR1 channels in lipid bilayers was enhanced
3-fold by cyclization. These functional changes were predicted
consequences of the structural enhancement. We suggest that
tethering the N and C termini stabilized secondary structural
elements in the DHPR II-III loop and may reflect structural and
dynamic characteristics of the loop that are inherent in EC
coupling.

The release of Ca2⫹ ions from the sarcoplasmic reticulum of
skeletal muscle fibers in response to depolarization of the surface membrane, excitation-contraction (EC)5 coupling, has
three essential molecular components. These are the cytoplasmic linker between the second and third transmembrane
repeats (the II-III loop) of the ␣1S subunit of the skeletal dihydropyridine receptor (skDHPR), the ␤1a subunit of the DHPR,
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and the skeletal muscle type 1 ryanodine receptor (RyR1). It is
generally accepted that membrane depolarization leads to the
movement of charged residues in the fourth membrane-spanning helix (S4 segment) of the ␣1S subunit and that this “charge
movement” causes a conformational change in the II-III loop,
which is physically transmitted to the RyR1 channel, to open
the ion channel and allow Ca2⫹ ion flow (1). The role of the
II-III loop in EC coupling has been extensively probed and confirmed over the past few decades using in vivo chimeric techniques (2–5), and the critical regions and residues involved in
this process have been identified (3, 6). Physical interactions
between the II-III loop and RyR1 are also seen in in vitro studies,
which reveal an increase in the activity of RyR1 channels when
they are exposed to the recombinant DHPR II-III loop (7–10).
However, in vitro structure and function studies of the II-III
loop have thus far been performed with loop constructs
expressed as a linear protein with free or untethered N- and Cterminal ends. Although the ends of the untethered loop are in
close proximity in the three-dimensional structure (11), the
geometrical constraints are obviously very different from those
experienced in the intact protein, where the N and C termini of
the loop are “tethered” to the S6 helix of the second transmembrane repeat and the S1 helix of the third transmembrane
repeat, respectively, both of which are inserted in the membrane of the transverse tubule extensions of the fiber surface.
To more closely mimic the tethered nature of the II-III loop
N and C termini in the intact membrane-bound protein and the
in vivo situation, we have used an intein-based method to link
the N- and C- terminal ends of the loop. Intein-mediated protein splicing is a post-translational reaction in which a precursor protein undergoes self-catalyzed head-to-tail intramolecular rearrangement with the consequent exclusion of an internal
protein domain and the formation of a mature intein protein
(12, 13). Intein-mediated protein splicing has been used extensively in biotechnology in the purification of recombinant proteins, ligation of polypeptides, and the synthesis of protein
microarrays, where it links the protein with a solid surface binding domain (14). Intein-mediated cyclization has also proved a
useful tool for investigating the stability of native fold proteins
(15).
In this study, we used the cyanobacterium Synechocystis sp.
strain PCC6803 DnaB 429 amino acid intein protein to generate a split functional N- and C- terminal intein (16). The terminal inteins come together to form a functional protein splicing
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domain that was engineered to contain the DHPR II-III loop.
We found that tethering the ends of the II-III loop increased
␣-helical and ␤-strand structure in particular regions of the
loop involved in key protein-protein interactions and EC coupling. This structural change strikingly increased the affinity of
the II-III loop for the SPRY2 domain and enhanced its ability to
activate RyR1 channels in lipid bilayers.

EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of the Linear and Cyclic
II-III Loop—The linear II-III loop was cloned, expressed, and
purified as we have previously described (11). For the intein
plasmid construction, the pNW1120 vector, which houses the
Synechocystis sp. strain PCC6803 DnaB split intein gene, was
used (kindly donated by Pavel Prosselkov from the Australian
National University Research School of Chemistry). The vector
carried nucleotides encoding a 9-amino acid residue linker
(TRESGSIEF). The linker length was chosen to avoid conformation strain and interference with the structure of the cyclized protein (15, 17). The linker was used as the initiation point
of intein-mediated protein cyclization via the serine and glutamate residues.
The vector was linearized using endonuclease digestion with
1 unit each of MluI (New England BioLabs) and EcoRI (New
England BioLabs) at 37 °C for 1 h, in the presence of 1⫻ NEB
buffer 3 (New England BioLabs). The cleaved product was
resolved on an agarose gel, visualized under UV light, immediately excised from the gel, and purified using the QIAQUICK
gel extraction kit following the manufacturer’s instructions
(Qiagen).
As previously described, the expression vector (18) hosting
the Oryctolagus cuniculus skDHPR II-III loop gene (9) was used
as a template to amplify the skDHPR II-III loop cDNA and add
an EcoRI site and His6 codons at the 5⬘-end and an MluI site at
the 3⬘-end. The amplification was carried out with primers
DHPRiHF (5⬘-GAGAATTCCACCATCACCATCACCATGAGGCGGAGAGCCTG-3⬘) and DHPRiR (5⬘-GTACGCGTCAGGACACGGACCTTATTG-3⬘) (GeneWorks) in a 20-l
reaction mix containing PCR buffer (Promega), 1.75 mM
MgCl2, 0.2 mM dNTPs, 2 units of TaqDNA polymerase (Promega), 5 ng of DNA template, and 0.3 pmol of primers. PCR was
carried out for 35 cycles in the PTC-200 DNA Engine (MJ
Research). The 417-bp amplicon was subjected to agarose gel
electrophoresis at 50 mA, excised from the gel, and purified
with QIAQUICK gel extraction kit (Qiagen). After a 1-h digestion with MluI and EcoRI at 37 °C, in the presence of 1⫻ NEB
buffer 3 (New England BioLabs), the digested product was again
purified by agarose gel electrophoresis as described above.
The purified fragment was ligated into the linearized
pNW1120 vector in the presence of 1⫻ ligation buffer (Promega) and 10 units of T4 DNA ligase (Promega). The ligation
reaction was performed overnight at 4 °C, and the plasmid was
transformed into Escherichia coli DH5␣. The insertion and the
orientation of the fragment into the vector were confirmed by
MluI-EcoRI double digestion and ABI Prism DNA sequencing
(Applied Biosystems). The pNW1120 vector containing the
skeletal DHPR II-III loop gene (Fig. 1A) was then transformed
into the E. coli BL21 for recombinant protein expression. The
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BL21 inoculation culture was incubated and agitated overnight
in Luria Bertani (LB) broth supplemented with 100 g/ml
ampicillin at 30 °C and then transferred to a larger volume of LB
broth supplemented with 100 g/ml ampicilin, and agitationincubation at 30 °C continued until A600 was between 0.8 and
1.0. Protein production was induced by rapidly increasing the
incubation temperature to 42 °C, and incubation continued for
another 4 h. Cultures were then harvested by centrifugation
and stored at ⫺20 °C. The protein was purified using a method
similar to that described for the linear loop (11). For NMR samples, uniformly 15N-labeled and 13C/15N-labeled protein was
produced by growing the expression strain in M9 salt media
with 15NH4Cl and [13C]-glucose as the sole nitrogen and carbon
source.
Carboxypeptidase-Y Digestion—The purified protein was
digested with carboxypeptidase-Y (Cp-Y) (Roche Applied Science) to confirm the cyclization. The sample was first dialyzed
overnight against 100 mM sodium citrate buffer (BDH Chemicals, Australia), pH 6.5, at 4 °C and then incubated with Cp-Y
(the Cp-Y/protein ratio was 1:100 (v/v)) at 25 °C for 4 h. Aliquots were taken at 1-h intervals and run on 12% BisTris-Cl
denaturing PAGE at 200 V for ⬃40 min.
Synthesis of Linker-His6 Tag Peptide—A 15-residue peptide
(linker peptide) corresponding to the 9-residue linker and the
His6 tag inserted upstream of the cyclized skDHPR II-III loop
was synthesized by the Australian Cancer Research Foundation
Biomolecular Resource Facility using an Applied Biosystems
430A protein synthesizer with purification using HPLC (Shimadzu) and mass spectroscopy (MALDI TOF/TOFTM model
4800, Applied Biosystems). Stock peptide solution (1 mM) was
prepared in Milli-Q water (Millipore).
Nuclear Magnetic Resonance (NMR), Circular Dichroism
(CD), and Spectrofluorimetry Experiments—All NMR experiments for the cyclic II-III loop were performed using methods
previously employed for the linear II-III loop (11). The NMR
sample was made up of 100 M 15N/13C-labeled cyclic II-III
loop in 50 mM phosphate, 200 mM KCl buffer at pH 6.5. DSS was
added in one sample for internal reference for the chemical
shift. The temperature was maintained at 5 °C. NMR data were
recorded on a Bruker Avance 800-MHz spectrometer equipped
with a cryoprobe. Spectra were processed using Topspin version 1.3 (Bruker) and analyzed with Sparky version 3.0 (T. D.
Goddard and D. G. Koeller).
The linear and intein II-III loop protein fragments were
diluted to ⬃20 M for CD measurements, and the pH values
and solution conditions were adjusted to pH 6.5 and 10 mM
PO42⫺, respectively. Spectra were recorded on an Applied Photophysics Chirascan spectrometer at 20 °C. A cell with a 0.1-cm
path length was used for spectra recorded between 190 and 250
nm with a spectral bandwidth of 1 nm, a 0.5-nm step size at 0.5
s/point. Each spectrum was obtained by averaging several
scans, and the protein CD spectra were corrected for buffer
contributions. The temperature was controlled by a Melcor
peltier temperature controller. Fluoresecence binding experiments and analysis of loop binding to the recombinant SPRY2
protein were carried out as described previously (11).
VOLUME 286 • NUMBER 25 • JUNE 24, 2011
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FIGURE 1. Expression and characterization of the cyclic II-III loop. A, the pNW1120 skDHPR II-III loop expression vector with the His6 tag (gray box) and
nine-residue linker (white box). The location of Intein N and Intein C in the vector is shown by the red arrows (modified from Ref. 17). B, Coomassie Blue-stained
12% BisTris-Cl polyacrylamide gels containing Invitrogen BenchMarkTM prestained protein ladders (Invitrogen) in the left lanes. The linear skDHPR II-III loop and
the cyclic skDHPR II-III loop are in the right lanes. The dotted line passes through the 20-kDa marker. C, Coomassie Blue-stained 12% BisTris-Cl polyacrylamide
gels of the linear (left gel) and cyclized (right gel) skDHPR II-III loop after a 4-h digestion with carboxypeptidase-Y. The first lane in the left gel shows the 20-kDa
marker from the protein ladder. In each gel, lanes labeled U show the undigested protein, and lanes labeled 1– 4 show aliquots taken after 1– 4-h periods of
digestion. The dotted lines indicate the position of the undigested protein.

SR Vesicle Preparation and Single Channel Recording and
Analysis—Back and leg muscle from New Zealand White rabbits was prepared as described (19 –21). Artificial planar bilayers separating two baths (cis and trans) were formed, and SR
vesicles were incorporated as described previously (20 –22). In
general, SR vesicles incorporated in such a manner that the
cytoplasmic surface of the SR and RyRs faced the cis solution.
The orientation was confirmed by characteristic changes in
channel activity with changes in cis (cytoplasmic) [Ca2⫹]. For
channel incorporation, the solutions were as follows: cis, 230
mM CsMS, 20 mM CsCl, 1 mM CaCl2, and 10 mM TES (pH 7.4);
trans, 30 mM CsMS, 20 mM CsCl, 1 mM CaCl2, and 10 mM TES
(pH 7.4). After channel incorporation, the trans [Cs⫹] was
raised to 250 mM with the addition of 200 mM CsMS. The cis
solution was altered by the addition of ⬃4.5 mM BAPTA (1,2bis(2-aminophenoxy)ethane-N,N,N⬘,N⬘-tetraacetic acid) (free
[Ca2⫹] ⫽ 100 nM; confirmed using a Ca2⫹ electrode). Trans
[Ca2⫹] was maintained at 1 mM under all conditions. Channels
were identified as RyRs by their characteristic conductance and
block by 20 M ruthenium red at the end of the experiment.
Voltage is expressed as cytoplasm relative to lumen. Channel
currents were filtered at 1 kHz and sampled at 5 kHz (22). Voltage was changed between ⫹40 and ⫺40 mV every 30 s. Measurements were carried out at 23 ⫾ 2 °C.
Single channel parameters, open probability (Po), mean open
time (To), and mean closed times (Tc) were obtained using the
Channel 2 program (developed by P. W. Gage and M. Smith,
John Curtin School of Medical Research) (20 –22). Open and
closed times were collected into logged bins, and the square
root of the relative frequency of events (P1⁄2) was plotted against
the logarithm of the open (open circles) or closed times (filled
circles) in milliseconds (23). Channel activity was assessed from
JUNE 24, 2011 • VOLUME 286 • NUMBER 25

60 s of recording, 30 s at ⫺40 mV and 30 –90 s at ⫹40 mV under
each condition. Because all effects were independent of voltage
(Table 1), data from the two potentials were pooled and
included in calculations of average channel activity. The effect
of the linear II-III loop, the cyclized II-III loop, and the linker
proteins on native RyR1 channel activity was examined.
Statistics—Average data are presented as mean ⫾ S.E. The
significance of differences was tested using Student’s t test for
paired or unpaired data or the non-parametric sign test, as
appropriate. A p value of ⬍0.05 was considered significant.

RESULTS
Gel Analysis of II-III Loop Proteins—SDS-polyacrylamide
gels of the purified linear and cyclic skeletal DHPR II-III loop
proteins are shown in Fig. 1B. The theoretical molecular mass
for the linear skDHPR II-III loop is 14.1 kDa; however, it has a
relatively slow electrophoretic mobility and appears to run at a
high molecular mass as noted previously (9, 24). The inclusion
of the His6 tag and the 9-residue linker in the cyclic protein (Fig.
1A) increases its theoretical molecular mass to ⬃16 kDa. However, the change in conformation of the cyclized protein
increases its electrophoretic mobility, as seen with other cyclized proteins (25–27), so that it appears to be smaller than the
linear protein on the gel (Fig. 1B). The change in mobility is
consistent with cyclization of the protein.
The cyclical nature of the intein loop was confirmed by exposure to Cp-Y. Because cyclic proteins lack both N and C termini, they should be insensitive to exopeptidase-catalyzed proteolysis (25), whereas linear proteins are susceptible to
digestion. Fig. 1C shows a gradual reduction in size and intensity of the linear loop during a 4-h incubation, indicating that, as
expected, the linear protein was susceptible to Cp-Y proteolyJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Spectroscopic comparison of the linear and cyclic II-III loops.
A, CD spectra for the cyclized and linear skDHPR II-III loop. The linear loop has
a negative peak (filled arrow) at 198 nm, and the cyclized loop has two negative peaks (open arrows) at 208 and 222 nm. B, 15N HSQC NMR spectra for the
cyclized loop (green contours) overlaid on the spectrum for the linear II-III loop
(purple contours) spectra showing the distribution of amino acid residues.
Residues not affected by cyclization in the C region are labeled, whereas some
residues adjacent to the linker (Lys685 (K685) and Met686 (M686)) are also
labeled (underscored).

sis. In marked contrast, the cyclic II-III loop maintained a similar intensity and position during the 4-h incubation period,
indicating that it was not susceptible to digestion and implying
that the C-terminal end was not accessible. The undigested
linear protein did not show any change in density during the 4-h
incubation (not shown).
Cyclizing the Skeletal DHPR II-III Loop Promotes Structural
and Dynamic Change—The linear DHPR II-III loop is an
intrinsically unstructured protein that consists of several nascent ␣-helical secondary structures and turns (11). The
unstructured nature of the linear II-III loop is reflected in its CD
profile, where the spectrum displays a distinct minimum at 198
nm and a slight dip at 222 nm (Fig. 2A). Upon cyclization of the
II-III loop, however, a marked structural difference can be
observed in the CD profile (Fig. 2A). The CD spectrum for the
cyclic II-III loop is significantly broader than its linear counterpart and shows two shallow minima at 208 and 222 nm that are
indicative of a protein containing mainly ␣-helical and some
␤-sheet elements (28). The marked difference in structure suggests that cyclization may induce substantial secondary structure and potentially tertiary structural changes throughout the
II-III loop protein.

22592 JOURNAL OF BIOLOGICAL CHEMISTRY

In order to more closely investigate the structural implications of cyclization of the II-III loop protein, we carried out a
series of multinuclear NMR experiments on the 15N/13C uniformly labeled cyclized loop. A set of experiments that included
15
N edited total correlation spectroscopy and NOESY-HSQC,
HCCONH, and HNCA protocols were used to assign the NMR
resonances of cyclized loop. The complete sequential assignment for the non-proline residues of the original II-III loop
residues, including the inserted intein linker, was performed,
and the backbone assignment is shown in supplemental Fig. 1.
The numbering system relating to the II-III loop residues has
been maintained (i.e. residues 666 –790), whereas residues
comprising the intein linker and the six histidine residues in the
sequence have been assigned an alternative numbering system
as specified in the legends to Figs. 2B and supplemental Fig. 1.
Structural Comparison of the Linear and Cyclized DHPR IIIII Loop—Chemical shift mapping is a valuable and sensitive
indicator of changes in structure, and based on the sequential
backbone assignment, 1H/15N HSQC NMR chemical shift analysis was initially used to directly compare the chemical shift
resonances of the two II-III loop constructs. The core region of
the 1H/15N HSQC spectrum of the linear loop is shown in Fig.
2B with the cyclized DHPR II-III loop superimposed. Apart
from the presence of additional linker and histidine residues,
there are clear resonance shifts (⌬␦) between the linear and
cyclized spectra. However, it is also clear that the chemical
shifts of numerous residues remained unchanged. All clearly
identified changes are summarized in Fig. 3A. For orientation
and historical purposes, the II-III loop has been assigned four
arbitrary regions (29) (i.e. the A (residues Glu666–Leu690), B
(residues Pro691–Glu724), C (residues Phe725–Gln765), and D
regions (residues Leu766-Leu791)). Unsurprisingly, the N- and
C-terminal residues underwent the largest chemical shift
changes (⌬␦ ⬎0.1 for 1H or 0.5 for 15N), whereas the remaining
residues exhibited only modest (⌬␦ ⬍0.1 for 1H or 0.5 for 15N)
or no chemical shift changes. Aside from the terminal residues,
the major 15N chemical shift differences were clustered in the A
region, the adjacent B region, and the D region. Of these, the A
and B regions had been previously identified as forming nascent
␣-helical structures in the linear II-III loop (11, 30). In order to
expand upon this chemical shift analysis, we used the backbone
␣-carbon and side chain ␤-carbon chemical shift values, which
are regarded as a more accurate predictor of secondary structure for intrinsically unstructured proteins (31). This analysis
was performed by comparing the difference in secondary structure propensity (SSP) of the two constructs using a program
that combines different chemical shifts into a single residuespecific secondary structure propensity score (31). Due to the
severe overlap for H␣ chemical shift values, only the C␣ and C␤
chemical shift values were incorporated into this program, and
the SSP for the two constructs was assessed. Fig. 3B shows that
as previously determined in our studies, the A and B regions
have a tendency to adopt ␣-helical structures, with the A region
in particular showing almost a fully formed ␣-helix. More interestingly, however, is that cyclization resulted in an increase in
the SSP for the A and B regions of the intein compared with the
linear loop (72% versus 59% for residues 670 –706). Another
region of interest is the C region (labeled residues in Fig. 2B),
VOLUME 286 • NUMBER 25 • JUNE 24, 2011
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FIGURE 3. Spectral shifts in assigned residues occurring as a result of cyclization of the II-III loop. The A–D regions are shown at the top of A, with line
thickness reflecting ␣-helical strength. A, the top graph shows the 1HN chemical shift perturbations, and the lower graph shows 15NH chemical shift perturbations for the II-III loop residues indicated on the lower axis. The divisions of the loop into A, B, C, and D regions are indicated along the central bar. The magnitude
of change was calculated by comparing the 1H and 15N HSQC spectra of the cyclized II-III loop and the linear II-III loop. It is notable that the residues most
strongly affected by the cyclization are clustered in the A, B, and D regions of the II-III loop. B, SSP scores for the two II-III loop constructs. The purple bars denote
the linear whereas the green bars represent the intein II-III loop. Positive values denote ␣-helical structure propensity, and negative values represent ␤-strand
or extended structure propensity. A SSP score of 1 or ⫺1 corresponds to a fully formed ␣- or ␤-structure, respectively.

which is the “critical region” for skeletal EC coupling (32). For
residues 733–760 of the C region, we observe a significant
increase in ␤-strand or extended structure from 11% (linear) to
29.6% (intein). To explore these changes in secondary structure
further, 15N and 13C NOESY-based two- and three-dimensional experiments were carried out for the intein II-III loop
protein. This set of experiments revealed little change in the
NOE profile for the intein compared with the linear II-III loop
protein (data not shown) and detected no additional medium or
long range NOEs. Furthermore, careful examination of the A
and B helical regions or the C region showed little difference in
the NOE profile, suggesting that despite increases in secondary
structure propensity, the residual dynamic nature of these
regions is not reflected in NOE effects. These sets of NMR
experiments indicate that conventional NOE measurements
alone are not sufficient to detect slight changes in structure.
Dynamic Properties of the Cyclized II-III Loop—Spin-lattice
relaxation rates (R2) are an effective tool in evaluating the
dynamic properties of proteins and are capable of detecting
motional fluctuations within a protein occurring within a
microsecond to picosecond time scale. The dynamic consequences of cyclizing the II-III loop were examined by comparing the R2 values for the two II-III loop constructs and are
shown in Fig. 4. It is evident from this comparison that, overall,
JUNE 24, 2011 • VOLUME 286 • NUMBER 25

FIGURE 4. Transverse relaxation rates (R2) of the circular and the linear loop
as a function of residue number. A–D regions are shown at the top, with line
thickness reflecting ␣-helical strength. The black points denote the linear R2 values, whereas the blue points represent the intein II-III loop. The shaded regions
cover consecutive residues that undergo significant increase for the cyclized
loop.

the cyclized loop displays larger R2 values than its linear counterparts, indicating a global reduction in motional freedom.
This result is particularly prominent at the N- and C-terminal
JOURNAL OF BIOLOGICAL CHEMISTRY
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ends of the loop, where R2 differences of ⬃5 s⫺1 were observed.
This result is not unexpected, however; additional segments
throughout the cyclized protein also displayed elevated R2 values of ⬃4 –10 s⫺1 compared with the linear loop. The locations
of these residues coincide with ␣-helical regions (i.e. regions A
and B) previously found in the linear loop and maintained in the
cyclized construct. Notably, these helical regions are the key
interaction elements responsible for binding to the II-III loop to
the SPRY2 domain of RyR1. Several of the peaks belonging to
the A region of the cyclized loop, such as Lys675, Lys677, Glu682,
Lys685, and Met686, were broadened in the HSQC spectrum and
display larger R2 values compared with their linear loop counterparts. In addition to these regions, one segment located in
the center of the C region of the II-III loop (residues 737–745)
showed an increase in the R2 of ⬃40% (all regions with
increased R2 values are highlighted in gray in Fig. 4). Therefore,
the dynamic changes upon cyclization are not confined to the N
and C termini or the A and B regions and, importantly, also
occur in the critical region for EC coupling.
The II-III loop binds to the SPRY2 domain of RyR1 and activates RyR1 in in vitro studies through its A and B regions, and
the efficacy of both interactions depends on the helical nature
of these regions (11, 30). Therefore, we predicted that these in
vitro functions of the loop would be enhanced as a consequence
of the enhanced structure in the A and B regions. These predictions are examined below.
The Cyclic skDHPR II-III Loop Binds More Tightly to the
SPRY2 Domain of RyR1 in Vitro than the Linear Loop—The
SPRY domain belongs to a class of structural domains that was
first identified in the Dictyostelium discoideum tyrosine kinase
spore lysis A (SplA) and all three isoforms of the mammalian
RyR (33). Three SPRY domains are conserved in the RyR across
species (34), and we have previously shown that the DHPR II-III
loop binds with low micromolar affinity to the second of these
domains (SPRY2; Ser1085–Val1208) (11). Indeed, the helical
nature of the N-terminal residues of the II-III loop is essential
for the interaction between the loop and the SPRY2 domain.
Thus, we predicted that, with a modified helical composition in
its N-terminal part, the cyclic loop may bind with different
affinity than the linear loop to the recombinant SPRY2 domain.
Binding of the linear and cyclic loops to the SPRY2 domain was
compared using intrinsic tryptophan fluorimetry (Fig. 5). A KD
value of 0.6 ⫾ 0.05 M was measured for the cyclic II-III loop
binding to SPRY2, indicating an ⬃4-fold higher affinity than
the linear construct (2.3 ⫾ 0.1 M).
The Cyclic skDHPR II-III Loop Is a More Effective Activator of
RyR1 than the Linear Loop—The activity of channels was
recorded for ⱖ10 min after the addition of recombinant protein
to the cytoplasmic (cis) solution. The usual effect of the linear
loop (9, 10) was seen, with channel activity increasing with 10
and 50 nM, decreasing with 100 and 200 nM, and returning
toward the initial control levels after perfusion to remove the
protein (Fig. 6A). Similar changes in activity were seen with the
cyclic loop (Fig. 6B), although activation was greater and inhibition less than with the linear loop. The linker peptide did not
alter activity at concentrations of 10 –100 nM (Fig. 6C). A small
increase in activity with 200 nM linker peptide in Fig. 6C was not
reflected in the average data (Fig. 7).
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FIGURE 5. The relative fluorescence values of SPRY2 (F340) plotted as a
function of the concentration (M) of the linear loop (triangles) and cyclic
(squares) skDHPR II-III loop. The fluorescence values were corrected for
dilution effects and the fluorescence contribution arising from the quenchers. The data were analyzed as described previously (11), using a non-linear
regression fit to the relative fluorescence intensity at 340 nm (F340) as a function of quencher concentration (M). The curve fitting was performed using
the GraphPad Prism software (GraphPad Software), from which the Kd measurements were derived. The inset at the top shows the cyclic loop data and
curve using an expanded y axis.

FIGURE 6. Effects of the linear (A) and cyclic (B) II-III loops and the linker
peptide (C) on single RyR1 channel activity. In each panel, the recordings
show 3-s segments of representative channel activity recorded at ⫺40 mV
under control conditions before the addition of the construct and then after
the addition of 10, 50, 100, and 200 nM concentrations of each construct, as
indicated on the left. The final record in each panel was obtained after perfusion of the cis chamber to remove the protein from the solution.

The average values in Fig. 7 include data at ⫹40 and ⫺40 mV
(because the effects were not voltage-dependent; Table 1) and
are presented as relative changes in activity (calculated for each
channel) to reduce effects of variability between individual
RyR1 channels (35, 36), which is illustrated in Table 2. The
cyclized II-III loop was ⬃2-fold more effective in increasing the
open probability than the linear loop, indicating a stronger high
affinity activating effect after cyclization. The decrease in activity when loop concentration was increased from 50 to 100 nM
was ⬃4-fold with each construct, suggesting that cyclization
did not alter the loop’s ability to inhibit the channel. Channel
activity returned to control levels after removal of the linear
loop, whereas removal of the cyclic loop was followed by an
VOLUME 286 • NUMBER 25 • JUNE 24, 2011
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increase in activity to approximately double that of the initial
control value. This higher activity may have reflected stronger
binding and slower dissociation of the cyclic loop.
Effect of the Cyclic skDHPR II-III Loop on RyR1 Gating
Parameters—The changes in To and Tc underlying the changes
in Po are shown in Fig. 7, B and C. In general, the significantly
greater increase in Po with the cyclic loop (Fig. 7A) was due to
trends toward a greater increases in To and reductions in Tc.
The decrease in the relative Po at higher loop concentrations
(100 and 200 nM) was due to a significant increase in Tc, which

FIGURE 7. Average relative single channel parameters measured with
each concentration of the linear loop (filled bins), cyclic loop (hatched
bins), and the linker peptide (cross-hatched bins). Data are shown for relative open probability (A), mean open time (B), and mean closed time (C). Each
bar indicates the average ⫾ S.E. (error bars) of 4 – 8 measurements. The asterisk indicates a significant difference from the control data, the filled symbol
indicates a significant difference between the linear and cyclic loops at the
particular concentration. Data are presented as the log10 of the relative values
in order to better display values that were less than control.

was significantly greater in the linear loop. These effects on
channel gating suggest that the cyclic loop interacted most
strongly with the channel opening mechanism.
Effect of the Linear and Cyclic Loops on Open and Closed
Time Distributions—We examined the effects of the loop constructs on the distribution of open and closed times to further
explore the effects of the linear and cyclic loops on RyR1 gating.
The exponential fits to data from individual channels exposed
to the linear or cyclic loop constructs at three different concentrations are shown in Fig. 8, and the average time constants for
each construct over the range of concentrations are shown in
Fig. 9.
The data were fitted with either two or three exponential
components, and the appropriate fit was determined using least
squares analysis. In all cases where three exponentials were
used rather than two, the sum of the squares for triple fit was
lower than that for the double fit, and the differences were on
average significant (Table 3).
Open times for RyR1 under control conditions fell into two
exponential components, and a third longer component was
introduced after the addition of 10 and 50 nM concentrations of
the loop constructs and was maintained with the cyclic loop,
but not the linear loop, at higher concentrations of 100 and 200
nM. The shortest open time constant, o1, was 1–3 ms, and the
second time constant, o2, was 5–12 ms. The longest time constant, o3, seen only in channels in the presence of the loop
constructs, was 50 –100 ms. The increase in mean open time in
the presence of the loop (Fig. 7) was largely due to the appearance of the o3 component. The mean open time tended to
remain higher with higher loop concentrations (ⱖ100 nM) of
the cyclic loop than the linear loop (Fig. 7). This can be attributed to the continued presence of o3 with higher cyclic loop
concentrations.
Closed times for RyR1 channels fell into three exponential
components under all conditions. The shortest closed time
constant, tc1, was 2– 4 ms, and the second time constant, tc2, was
10 – 40 ms. The longest time constant, tc3, was 300 – 400 ms
under control conditions and increased to ⬃1000 ms with a 200
nM concentration of the linear loop. In marked contrast, tc3
decreased to 100 –200 ms in the presence 10 –100 nM cyclic
loop and then increased toward control values with 200 nM
cyclic loop, where it contained the majority (60%) of events. The
very long tc3 with 200 nM linear loop is largely responsible for
the long closed times with this construct. The shorter tc3 values

TABLE 1
There is no voltage dependence in the effects of the linear or cyclic loop on RyR1 channel Po

Average relative Po at ⫹40 and ⫺40 mV (relative to activity prior to construct addition), in the presence of 10, 50, 100 and 200 nM concentrations of each construct (linear,
cyclic, and linker) and after washout by perfusion of the cis chamber.
Construct concentration
Construct

10 nM

50 nM

100 nM

200 nM

Washout

Linear
⫹40 mV
⫺40 mV

1.75 ⫾ 0.03
1.95 ⫾ 0.30

3.77 ⫾ 0.24
3.65 ⫾ 0.50

0.34 ⫾ 0.09
0.62 ⫾ 0.04

0.33 ⫾ 0.07
0.56 ⫾ 0.05

1.01 ⫾ 0.07
0.88 ⫾ 0.04

Cyclic
⫹40 mV
⫺40 mV

2.98 ⫾ 0.56
2.94 ⫾ 0.64

5.73 ⫾ 0.83
5.63 ⫾ 1.56

1.49 ⫾ 0.26
1.65 ⫾ 1.06

1.07 ⫾ 0.35
1.18 ⫾ 0.67

2.24 ⫾ 0.16
2.10 ⫾ 0.25

Linker
⫹40 mV
⫺40 mV

0.80 ⫾ 0.15
0.92 ⫾ 0.11

0.77 ⫾ 0.13
0.94 ⫾ 0.06

0.63 ⫾ 0.27
0.90 ⫾ 0.14

1.27 ⫾ 0.49
0.84 ⫾ 0.15

0.90 ⫾ 0.19
0.82 ⫾ 0.09
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TABLE 2
Control parameter values for RyR1 channels prior to exposure to each
of the constructs
The variability between average values for each set of experiments illustrates normal
variability between RyR1 channels.
Po
Linear loop
Cyclized loop
Linker

0.11 ⫾ 0.07
0.09 ⫾ 0.03
0.22 ⫾ 0.06

To

Tc

ms

ms

10.1 ⫾ 6.4
3.1 ⫾ 0.6
2.8 ⫾ 0.4

122 ⫾ 38
80 ⫾ 21
23 ⫾ 6

FIGURE 9. Effects of the linear and cyclic loops on the average open (A and
B) and closed (C and D) time constants. The probability of events falling into
each time constant is plotted against the time constant in ms (open time or
closed time). Time constants are shown for control data (filled circles), 10 nM
loop (open circles), 50 nM loop (open squares), 100 nM loop (open diamonds),
and 200 nM loop (crosses). The red circles indicate regions of major difference
between the effects of the linear and the cyclic loops, which are primarily in
o3 and c3. Data from four bilayers were analyzed for the linear loop and
seven bilayers for the cyclic loop. Each data point is the average of 8 –16
measurements (at ⫹40 and ⫺40 mV) for the linear and cyclic loops, respectively. Error bars indicate S.E.

FIGURE 8. Effects of the linear and cyclic loop constructs on the distribution of open and closed times. Exponential open and closed time constants
were determined. Open and closed times were collected into logged bins,
and the square root of the relative frequency of events (P1⁄2) was plotted
against the logarithm of the open (open circles) or closed times (filled circles) in
ms (23). Examples are shown for data from individual channels under control
conditions (A and D) and after exposure to 50 nM linear and cyclic loops (B and
E) and then 200 nM linear and cyclic loops (C and F). The numbers of events
generally varied between 500 and 1000. The broken lines in each graph show
the fit of multiple exponential functions to the data. The arrows indicate individual open time constants (o1, o2, and o3) and individual closed time constants (c1, c2, and c3). The variables o3 and c3 (see description under
“Results”) are shown in red and blue, respectively. A–C, exposure to linear
loop. D–F, exposure to cyclic loop.

contribute to the briefer closed times with 200 nM cyclic loop
than with the linear loop. These results again indicate that the
cyclized loop may interact more strongly with the channel
opening mechanism than the linear loop.

DISCUSSION
Until now, in vitro structural and functional investigations of
the II-III loop fragment of the DHPR ␣1S subunit have been
limited to a linear construct of this loop with untethered ends
(8 –11, 24). However, the unrestrained ends of the loop are not
a true representation of the physiological state, where the termini are anchored to membrane-spanning segments. We have
used intein-mediated technology to effectively fuse the N and C
termini of the loop with the aid of a linker peptide. We show for
the first time that cyclization results in significant structural
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changes in several parts of the loop, including the critical region
for EC coupling and in other regions essential for the in vitro
function of the loop. Changes in the in vitro function of the
protein were observed and were consistent with the structural
changes.
Functional Changes in the Cyclic II-III Loop Are Correlated
with Structural Changes—In vitro, the linear skeletal DHPR IIIII loop is an activator of RyR1 (8, 9, 24). The ability of the linear
II-III loop to activate native skeletal RyR channels was clearly
enhanced with the cyclic loop. We have previously demonstrated that the helical content of a peptide with a sequence
corresponding to the A region of the II-III loop is inextricably
linked to the peptide’s ability to activate RyR1 channels (37, 38)
and show here that the cyclic II-III loop is 2– 4-fold more potent
in increasing the open probability of the RyR1 channel than its
linear counterpart. This increased ability to activate the RyR1
channel is consistent with the stabilization of the helical components of the A and B regions.
High Affinity Binding of the Cyclized Loop to the SPRY2
Domain of RyR1—SPRY domains contribute to protein-protein
interactions (39, 40), and several studies suggest that the RyR1
SPRY2 domain (Ser1085–Val1208) plays a role in the in vitro
interactions between the II-III loop and RyR1. The skeletal IIIII loop can pull down a 37-amino acid residue fragment of the
RyR1, containing Arg1076– Asp1112 (41), and the A region of the
skeletal DHPR II-III loop interacts with residues Val1021–
Glu1631 of the RyR1 (42). These two sequences overlap with the
N-terminal end of the RyR1 SPRY2 domain, and the linear II-III
loop binds to the recombinant SPRY2 domain through the A
and B region (11, 30, 34) with a Kd of 2.3 ⫾ 0.1 M, which is
critically dependent on the presence of five basic residues in the
VOLUME 286 • NUMBER 25 • JUNE 24, 2011

RyR1 Activation by a Cyclic II-III Loop
TABLE 3
Average values for the sum of least squares differences between data and curves fitted to the data assuming either two (o2, c2) or three (o3,
c3) exponential components for open and closed time distributions
The asterisks and boldface type indicate instances in which the use of three components resulted in a significantly better fit to the data.
Open time distribution

Closed time distribution

o2

o3

c2

c3

Linear loop
Control
10 nM
50 nM
100 nM
200 nM

0.0263 ⫾ 0.0056
0.0205 ⫾ 0.0055
0.0229 ⫾ 0.0052
0.0292 ⫾ 0.0084
0.0449 ⫾ 0.0008

0.0253 ⫾ 0.0055
0.0147 ⫾ 0.0035
0.0184 ⴞ 0.0043*
0.0323 ⫾ 0.0101
0.0439 ⫾ 0.0001

0.0497 ⫾ 0.0150
0.0462 ⫾ 0.0094
0.0387 ⫾ 0.0095
0.2850 ⫾ 0.1235
0.6674 ⫾ 0.3633

0.0413 ⴞ 0.0145*
0.0274 ⴞ 0.0059*
0.0274 ⴞ 0.0073*
0.2272 ⴞ 0.0976*
0.6254 ⴞ 0.3582*

Cyclic loop
Control
10 nM
50 nM
100 nM
200 nM

0.0146 ⫾ 0.0019
0.0139 ⫾ 0.0034
0.0185 ⫾ 0.0032
0.0239 ⫾ 0.0062
0.0229 ⫾ 0.0056

0.0151 ⫾ 0.0019
0.0099 ⴞ 0.0002*
0.0107 ⴞ 0.0023*
0.0217 ⴞ 0.0063*
0.0188 ⴞ 0.0055*

0.0368 ⫾ 0.0076
0.0241 ⫾ 0.0065
0.0181 ⫾ 0.0051
0.0244 ⫾ 0.0085
0.0532 ⫾ 0.0244

0.0211 ⴞ 0.0037*
0.0114 ⴞ 0.0026*
0.0131 ⴞ 0.0053*
0.0186 ⴞ 0.0068*
0.0264 ⴞ 0.0117*

A region ␣-helix (Arg681–Lys685) and two adjacent lysine residues (Lys703 and Lys704) in the B region ␣-helix (30).
The cyclized wild type II-III loop, with a Kd of 0.6 ⫾ 0.05 M,
has a higher affinity for the RyR1 SPRY2 than its linear counterpart. Because the A and B regions are major contributors to
the increased ␣-helical content of the cyclized II-III loop, it is
likely that this structural stabilization in the cyclized II-III loop
is correlated with the 4-fold higher affinity for the SPRY2
domain. It is also likely that the tighter binding of the cyclized
loop to the SPRY2 domain is linked to the enhanced activation
of RyR1 channels. Thermodynamically, the increase in RyR1
binding and activity by the cyclic construct can be explained by
a smaller entropic loss upon binding brought about by the stabilization of the helical interaction sites (A & B regions).
Structural and Dynamic Changes with Cyclization of the
Loop—The marked shift in the CD profile of the cyclized protein provides compelling evidence of a change in the structure
of the II-III loop following cyclization. We have previously
reported that the linear II-III loop is an intrinsically unstructured protein with at least two nascent helical elements located
in the A and B regions (11). The NMR 15N and 1H chemical shift
data presented in Fig. 3a show that the most significant chemical shift changes occur not only in the N- and C-terminal residues adjacent to the linker residues but also in the regions
adjacent to the directly modified region, such as the A (Glu666–
Leu690) and B (Pro691–Glu724) regions of the loop. A more comprehensive chemical shift comparison using C␣ and C␤ chemical shifts (Fig. 3b) showed not only an increase in helical
structural propensity for this region but a marked increase in
extended ␤-strand structural propensity for the C region.
A series of three-dimensional NOESY-based NMR experiments revealed stable structural changes promoted by cyclization of the II-III loop. Notably, apart from new NOEs associated
with the linker region, no discernable overall difference in the
NOE profile between the linear and intein loop was evident.
Close inspection of signature NOEs related to the ␣-helical secondary structure elements (A and B regions) and extended
␤-strand structure (C region) also showed a similar profile for the
linear and intein loops. Therefore, cyclization does not promote
alternative, stable structures within the II-III loop but rather
results in subtle shifts in the equilibrium that exits between random coil and secondary structure elements. These subtle changes
JUNE 24, 2011 • VOLUME 286 • NUMBER 25

are detectable by spin-spin relaxation rate (R2) measurements,
and the increased R2 values for the A/B helical and C regions are
evidence of stabilization of the secondary structure elements
within the intein protein. In summary, the CD and NMR data
suggest that cyclization of the intrinsically unstructured DHPR
II-III loop does not involve major structural modifications but
instead induces subtle structural changes to the secondary structure elements of specific regions in the molecule and can dramatically influence the function of the protein.
Functional and Physiological Implications of Cyclization—It
is a generally held view that upon depolarization, movement of
charged residues in the membrane-spanning segments of ␣1s
DHPR is responsible for a conformational change in the II-III
loop, which in turn is transmitted to the RyR1. We convincingly
demonstrate by altering the geometry of the N- and C-terminal
ends of the II-III loop that the structural and dynamic consequences are sensed throughout the entire loop. This observation has significant implications for EC coupling, where movement of charged residues in the S4 voltage sensor, by analogy
with other voltage-gated cation channels, is likely to induce a
major structural change in the membrane-spanning domains
linked to the S4 segment (43). This structural reorientation of
the S1 to S4 helices could dramatically alter the structural relationship between the N- and C-terminal ends of the II-III loop
and alter the conformation of the II-III loop during EC coupling
to either increase or decrease its structural content.
Although the importance of the II-III loop in EC coupling
and the critical region for EC coupling identified in the central C region (residues 720 –765) has been long been established (44), knowledge of the interactive partners of the critical region within the loop in the coupling process is less
clear. Concerted attempts by several groups to define the
RyR1 binding partner for the critical C region have not been
successful, suggesting either that the RyR1 binding partner is
complex and remains elusive or that interactions of the C
region may proceed through some intermediate protein/factor. In contrast, the in vitro binding between the A and B
regions of the loop and the SPRY2 domain of RyR1 has been
well characterized (11, 30, 34). Indeed, an unpublished cryoelectron microscopy study of the location of the SPRY2
domain on the RyR1 has mapped this region on domain 6 of
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the RYR1.6 Although this location is within contact distance
with DHPR II-III loop, in vivo chimeric studies show that
when the A region has been removed or disrupted, EC coupling is not significantly affected and thus is not critical (5,
45). It remains possible that, although not critical in a dysgenic myotube background, the II-III loop A region/SPRY2
interaction may play a supportive role in EC coupling, which
may be revealed in transgenic animals in which a full range of
muscle function can be explored. Such supportive roles have
been found to be life-supporting in maintaining normal
muscle function under stress in both skeletal muscle and the
heart, in studies of other non-essential proteins, such as
calsequestrin, triadin, and junctin (46 – 48).
The major finding of this study is that both the helical A/B
region and the C region of the II-III loop are structurally altered by
cyclization and that this influences the biophysical properties of
the loop. The A/B region of the loop interacts in vitro with the
SPRY2 domain, and we demonstrated that a modest increase
(⬃13%) in helical content in this region of the loop was associated
with a 3–4-fold increase in RyR1 channel activity and binding
affinity. The most likely explanation for this increase is thermodynamic. The stabilized ␣-helical elements in the intein loop would
be more favorably predisposed to interact with SPRY2 RyR1 binding sites. This finding is consistent with our previous findings that
substituting strategic residues in the isolated A peptide (residues
671–690) led to the enhancement of its helical structure and subsequently its increased ability to activate RyR1 (37, 49). Because the
interactive binding partner of the central C region of the II-III
loop has yet to be established, it is not possible to perform a
comparable structural and functional analysis for this region. It
is possible that the changes in channel gating induced by cyclization are imposed by an interaction between the more structured C region and a binding partner in RyR1. However, the
substantial increase in ␤-strand or extended structure found in
the C region may allow the identification of new RyR1 binding
partners using this improved construct.
Conclusion—We find that cyclization of the skeletal DHPR IIIII loop affects the secondary structure and the dynamic properties
of the helical A/B region as well as the critical C region. These
structural effects are correlated with a change in the in vitro activation profile of the RyR1 and with an interaction with DHPR II-III
loop ␣-helical recognition sites in the SPRY2 domain of RyR1. The
results provide a clear example of how subtle structural and
dynamic changes in an intrinsically unstructured protein may
affect molecular recognition. Also, the critical region of the loop
that supports skeletal in vivo EC coupling demonstrated an
increased ␤-strand or extended structure upon cyclization, indicating that this portion of the loop is susceptible to structural and
dynamic changes, with functional consequences, induced by t-tubule membrane depolarization.
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21. Wei, L., Varsányi, M., Dulhunty, A. F., and Beard, N. A. (2006) Biophys. J.
91, 1288 –1301
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